Rhu Jinsoo, Cho Chan Woo, Lee Kyo Won, Park Hyojun, Park Jae Berm, Choi Yoon-La, Kim Sung Joo
From the Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (Rhu, Cho, Lee, H. Park, J. Park, Kim); and the Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (Choi).
Can J Surg. 2017 Dec;60(6):399-407. doi: 10.1503/cjs.005917.
This study was designed to analyze differences between retroperitoneal liposarcoma (RLPS) extending into the inguinal canal and inguinoscrotal liposarcoma.
We retrospectively reviewed the records for patients who were managed for inguinal liposarcoma at Samsung Medical Center, a tertiary hospital, between January 1998 and December 2016. Patient data on demographics, tumour location, surgery, adjuvant therapy, histology, recurrence and death were collected. We used Mann-Whitney, Fisher exact and Kaplan-Meier log-rank tests to analyze differences between groups.
Seven of 179 (3.9%) patients with abdominal liposarcoma had inguinoscrotal liposarcoma, and 6 of 168 (3.6%) patients with RLPS had extension to the inguinal canal. No differences were observed between groups in sex ( > 0.99), mean age (49.7 ± 6.4 yr v. 52.1 ± 12.5 yr, = 0.37), laterality ( > 0.99) or scrotal involvement (40.0% v. 66.7%, = 0.57). The RLPS group had significantly larger tumours than the inguinoscrotal group (27.9 ± 6.8 cm v. 7.8 ± 4.2 cm, = 0.001). Postoperative complications were significantly more common in the RLPS group ( = 4, 83.3%); patients in the inguinoscrotal group experienced no postoperative complications ( = 0.021). Log-rank tests showed that the groups had no statistical differences in disease-free survival ( = 0.94) or overall survival ( = 0.10). However, inoperable disease-free survival was significantly poorer in the RLPS group ( = 0.010).
Although initial signs and symptoms can be similar, RLPS extending into the inguinal canal was associated with significantly higher morbidity and mortality than inguinoscrotal liposarcoma.
本研究旨在分析延伸至腹股沟管的腹膜后脂肪肉瘤(RLPS)与腹股沟阴囊脂肪肉瘤之间的差异。
我们回顾性分析了1998年1月至2016年12月在三级医院三星医疗中心接受腹股沟脂肪肉瘤治疗的患者记录。收集了患者的人口统计学、肿瘤位置、手术、辅助治疗、组织学、复发和死亡等数据。我们使用Mann-Whitney检验、Fisher精确检验和Kaplan-Meier对数秩检验来分析组间差异。
179例腹部脂肪肉瘤患者中有7例(3.9%)患有腹股沟阴囊脂肪肉瘤,168例RLPS患者中有6例(3.6%)延伸至腹股沟管。两组在性别(>0.99)、平均年龄(49.7±6.4岁对52.1±12.5岁,P=0.37)、侧别(>0.99)或阴囊受累情况(40.0%对66.7%,P=0.57)方面未观察到差异。RLPS组的肿瘤明显大于腹股沟阴囊组(27.9±6.8 cm对7.8±4.2 cm,P=0.001)。RLPS组术后并发症明显更常见(n=4,83.3%);腹股沟阴囊组患者未出现术后并发症(P=0.021)。对数秩检验显示,两组在无病生存期(P=0.94)或总生存期(P=0.10)方面无统计学差异。然而,RLPS组的不可手术无病生存期明显较差(P=0.010)。
尽管初始体征和症状可能相似,但延伸至腹股沟管的RLPS与腹股沟阴囊脂肪肉瘤相比,发病率和死亡率明显更高。